Epithelial ovarian cancer has the highest mortality rate among the gynecologic cancers and spreads beyond the ovary in 90% of the women diagnosed with ovarian cancer. Detection before the disease has spread beyond the ovary would significantly improve the survival from ovarian cancer, which is currently only 30% over 5 years, despite extensive efforts to improve the survival. This study describes initial investigation of the use of optical technologies to improve the outcome for this disease by detecting cancers at an earlier and more treatable stage. Women undergoing oophorectomy were recruited for this study. Ovaries were harvested for fluorescence spectroscopy, confocal microscopy, and optical coherence tomography. Fluorescence spectroscopy showed large diagnostic differences between normal and abnormal tissue at 270 and 340 nm excitation. Optical coherence tomography was able to image up to 2mm deep into the ovary with particular patterns of backscattered intensity observed in normal versus abnormal tissue. Fluorescence confocal microscopy was able to visualize sub-cellular structures of the surface epithelium and underlying cell layers.
Introduction
Ovarian cancer goes undetected in both developed and developing countries because adequate technology does not exist to detect preinvasive or early stage disease. There are approximately 25,600 new cases of ovarian cancer in the United States per year, and an estimated 16,000 deaths from ovarian cancer in 2004 (1, 2). Although ovarian cancer accounts for only 4% of all new cancer cases, it is the fifth leading cause of cancer-related mortality in women, and the leading cause of death from gynecologic malignancies (3). High prevalence of late-stage disease and the poor prognosis associated with these later stages are the major factors that give ovarian cancer patients such a dismal prognosis. Women with disease localized to the ovary have a 5-year survival of 80-90%, while women with Stage III disease have a 5-year survival of 30% or less. With our current screening and diagnostic abilities, 70% of women will continue to be diagnosed with FIGO Stage III or IV disease (widespread intra-abdominal disease) and the majority of them will die of their disease (3). The conservative cost of treatment for ovarian cancer is estimated at least $15 billion dollars/year (4-6), due primarily to the late stage of diagnosis, the high morbidity associated with treatment, and the high rate of recurrence.
Pathology and Risk Status:
After the optical measurements, tissue was fixed and processed with standard histological procedures. Slices of the biopsy corresponding to the optical measurement were digitally photographed at a microscopy workstation. Pathology results were obtained from each ovary at University Medical Center and were examined by a single pathologist (J. D.). Both gross and microscopic pathology were analyzed on the entire ovary as is standard practice on all clinical specimens. In addition, each biopsy originating from the ovary was also examined by the pathologist to confirm that the area imaged was correctly categorized pathologically. The area that was imaged was closely correlated with the tissue biopsy by first marking the area imaged and then slicing this area for H and E staining after processing.
For each patient, the risk status for developing ovarian cancer was determined by the genetic counselor (K. H.). High risk patients were classified based on a personal or family history of breast and/or ovarian cancer, using the Parmigiani method (7). All patients classified as high risk had an increased risk of ovarian cancer: a few were known to have mutations of the BRCA gene which confers a higher risk of ovarian cancer than women without mutations. Samples were stratified into four main categories: normal ovary (no structures except stroma, epithelium, corpus albicans and corpus luteum), benign neoplasm (abnormal growth without invasive areas), endometriosis (growth of both endometrial glands and stroma on the ovary), or cancer (invasion of carcinoma into the ovary). The risk status was low risk (normal risk for developing ovarian cancer) or high risk (increased risk or a normal ovary on the contralateral side to an ovary with cancer), and cancer. The categories were normal-low risk, normal-high risk, normal (including high and low risk), benign (including benign neoplasm and endometriosis), and cancer.
Fluorescence Spectroscopy
A table top spectroscopy system was used to collect fluorescence data from ovarian tissue ex vivo. The spectroscopy system consisted of a scanning fluorometer with double excitation and emission spectrographs (Fluorolog 3-22, JY Horiba, Edison, NJ) and a custom fiber-optic probe which was coupled to the spectrographs with a fiber-optic adapter placed in the sample chamber ( Figure 1a) . The fiber-optic probe interrogated a spot of 800 micron diameter. Using this system, emission spectra ranging from 290 nm to 700 nm at fifteen excitation wavelengths between 270 nm to 550 nm were measured in approximately 4 minutes. The probe (Figure 1a ) was positioned in contact with the surface epithelium allowing the weight of the probe to contact the tissue. Spectra were recorded from at least three locations on each biopsy. Positive standards were based on solutions of Rhodamine, Fluorescein and Quinine (Molecular Probes, Eugene, OR) and negative standards were deionized ultra filtered water. Prior to every measurement, the system was calibrated with a set of positive and negative standards assuring wavelength and intensity calibration, as well as accurate background removal. Data were reviewed by two of our investigators (N. K., U. U.) and no data had to be excluded due to device malfunctioning.
Fluorescence Spectroscopy Analysis: Excitation emission matrices (EEMs) were assembled in MATLAB (Mathworks Inc., Natick, MA) (8, 9). See Figure 2a for an illustration of a normal ovary. Each EEM was area-normalized. For this exploratory data analysis, samples were broken down into three groups, normal (including high and low risk), benign (includ-ing benign neoplasm and endometriosis), and cancer. A mean and standard deviation EEM was calculated for each group and P-values were calculated at all wavelengths to compare differences between the means of the groups. Areas of interest within the EEM were regions with a P-value of less than 0.05. A set of excitation and emission wavelengths were established where P-values between groups were consistently different.
Optical Coherence Tomography (OCT)
The ovary specimens were imaged by OCT usually within 3-6 hours of surgical removal. Samples were maintained in a RPMI
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Technology This diagram illustrates the fiberoptic probe used for fluorescence measurements. This probe is coupled to a table top fluorescence spectrophotometer and consisted of a standard 6 around 1 fiber configuration (200 micron core diameter). The 7 fibers are connected to a larger diameter fiber homogenizing illumination and collection (800 micron core diameter). The end of the probe is obliquely polished to avoid specular reflection from being coupled in the detection channel. The photograph illustrates a size comparison to an adult human finger. The system contains a broadband source and a red aiming laser combined and coupled into one branch of a fiber optic Michelson interferometer, a 2 × 2 coupler to split light, one leading to a reference mirror and the second to a probe that focuses light on the tissue, a reference mirror from which reflected and backscattered light is recombined within the 2 × 2 coupler, and an AC coupled photovoltaic detector detected interference fringe intensity. This diagram illustrates the custom slit-scan confocal microscope coupled to a fiber-optic catheter with the Argon ion laser and the Krypton ion laser which are coupled to a beam combiner. The light bounces off the scan mirror and is re-imaged by a microscope objective onto the input face of the fiber optic imaging bundle which relays the line focus to the distal end of the fiber bundle, where it is imaged inside the sample (tissue) at a selected depth by the miniature objective. The fluorescent light passes back through the fiber, through the microscope objective, back off the scan mirror, and is reflected by a dichroic beamsplitter. The dichroic beamsplitter transmits the illumination light while reflecting the longer wavelength fluorescence light. The fluorescent light is imaged onto the confocal aperture slit.
Figure 1d:
The fiber optic catheter is the key component of the confocal micro-endoscope and allows it to be used for in vivo imaging and consists of a miniature objective lens and focus mechanism coupled to a fiber optic imaging bundle. The current catheter uses a fiber-optic imaging bundle which has 30,000, 2 µm core-diameter, optical fibers with center-to-center fiber spacing is approximately 3 µm and the diameter of the active imaging area of the bundle is 729 µm.
culture medium (Media Tech) to minimize degradation and kept moist with culture medium while being imaged. The OCT measurements were taken from the same biopsy of tissue. Approximately 10 cross-sectional images, each 6 mm in laterally and 1.4 mm deep, and were taken spaced 1 mm apart. Fiducials were marked with tissue dye on the sample to facilitate registration of OCT images and histology. This was done on the side of the biopsy to avoid any contamination of the area imaged.
A simple OCT system ( Figure 1b ) was utilized for this study, similar to one described in a prior publication (10). The system operated as follows: light emitted from a broadband source and a red aiming laser was combined and coupled into one branch of a fiber-optic Michelson interferometer. Light was split into two fibers using a 2 × 2 coupler, one leading to a reference mirror and the second to a probe that focused light on the tissue. Light reflected from the reference mirror and backscattered by the sample recombined within the 2 × 2 coupler. When the optical path length difference between light in the sample and reference arms was within a coherence length of the source (approximately 14 µm), interference was observed. An AC coupled photovoltaic detector is 620 Brewer et al.
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Figure 2: Fluorescence spectroscopy study. a) Illustrates an average fluorescence excitation emission matrix of normal ovarian tissue. Areas of higher intensity are indicated with brighter colors. Emission below 320 nm excitation is consistent with the emission of amino acids, mainly tryptophan while metabolic co-factors and structural proteins contribute to the emission above 320 nm excitation. The largest differences between tissue groups were observed at 270 and 340 nm. Average emission spectra at 270 nm excitation of normal, benign neoplasm and cancer tissue are plotted and the normal group is further divided into tissue from patients at high risk and low risk for developing ovarian cancer. Differences are statistically significant between the three main groups with the cancer group having the highest emission and the benign group the lowest. used to detect interference fringe intensity. Longitudinal movement of the reference mirror changed the optical path length, caused reflected light from various depths within the sample to be detected, and induced a signal modulation. The detector output was demodulated to obtain a signal envelope proportional to the magnitude of backscattered light within the sample. The signal was digitized and processed using a computer to form a two dimensional image of the tissue.
The system utilized a super luminescent diode (Superlum D1300-HP, Superlum Ltd., Moscow, Russia) with a 1300 nm center wavelength, full-width half-maximum bandwidth of 60 nm and 5 mW output. The power on the tissue was approximately 2 mW. The axial resolution of the system was approximately 10 µm in tissue, assuming an average index of refraction of 1.4. The lateral resolution (minimum beam waist) was set to 13 µm by the sample arm optics. Lateral scanning was achieved by translating the sample with a motorized stage. A block diagram of the OCT system is shown in Figure 1b .
Confocal Micro-endoscope
A fluorescence confocal micro-endoscope system developed at the University of Arizona was used in this study. Details of this system have been described elsewhere (11-13). Briefly, the system consists of a custom slit-scan confocal microscope coupled to a fiber-optic catheter (Figure 1c) . The slit-scan microscope allows rapid confocal scanning at frame rates up to 20 fps, which is important for real-time in vivo imaging. The catheter of the confocal micro-endoscope consists of a miniature objective lens and mechanical focus mechanism coupled to a fiber-optic imaging bundle. The catheter uses a fiber-optic imaging bundle (IGN-08/30, Sumitomo Electric, White Plains, NY) with 30,000, 2 µm core diameter, optical fibers. The center-to-center fiber spacing is approximately 3 µm and the diameter of the active imaging area of the bundle is 729 µm. The diameter of the fiber bundle with silica jacketing and outer coating is 928 µm. The numerical aperture (NA) of this bundle is 0.35. The objective lens images the face of the fiber bundle to a selected depth in the tissue. The magnification of the objective lens is 1.6 from tissue to fiber so the field of view in the tissue is 456 µm, and the NA of the beam from tissue is approximately 0.5. The lens is designed to be nearly diffraction limited with a Modulation Transfer Function (MTF) of greater than 0.5 at 266 lp/mm in tissue, which corresponds to the effective cutoff frequency for the fiber bundle. The overall lateral resolution of the system in tissue is approximately 2 µm and the axial resolution is 25 µm.
When in operation, the front surface of the objective lens (a flat cover slip) is placed in contact with the tissue. The focus mechanism allows the fiber to be moved relative to the objective to adjust the focal depth in the tissue. The fiber moves inside a plastic tubing attached to the objective lens. The maximum diameter of the catheter is 3 mm, which is small enough to allow it to be routed through the instrument channel of many clinical endoscopes. The system is designed to accommodate a focal depth in tissue of from 0 to 200 µm. Figure 1d shows a picture of the confocal micro-endoscope and the tip of the micro-endoscope catheter. The same tissue areas were interrogated with the confocal micro-endoscope. The micro-endoscope probe was placed in contact with the tissue and the focus adjusted for best image quality. For all of the imaging work performed in this study with the fluorescence confocal micro-endoscope, 100 µ of 33 µM Acridine orange (AO) was administered topically to the surface of the excised tissue prior to imaging. Acridine orange is a vital fluorescent stain that is rapidly taken up by living cells, and stains both DNA in the nucleus and RNA in the cytoplasm.
Results
Twenty patients were recruited and measured in this study. Ages ranged from 18 to 77 years with a mean age of 50 +/-16 years. Nine women were pre-menopausal, three were peri-menopausal, and eight were post-menopausal. The majority of ovaries were measured with all three imaging modalities (Table I ). In some cases biopsies from both ovaries were measured and in other cases only one ovary was measured. Lack of availability of or malfunction of instrumentation were the most common reasons some tissue was measured with only one or two of the technologies.
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Technology One set of measurements was excluded because the final pathology disagreed with the initial diagnosis of cancer; the patient had received several courses of chemotherapy and did not have residual cancer on the ovaries. Measurements from another patient were excluded because of an infarct in the ovary resulting in non-viable, necrotic tissue.
Fluorescence Spectroscopy
A total of 86 measurements from 17 patients were available for analysis. The largest categories included 32 measurements from the normal-low risk category (9 biopsies), 21 measurements from the normal-high risk category (7 biopsies), and 21 measurements from the cancer group (6 biopsies). Twelve measurements from 4 biopsies were available for the benign group. Several patients provided biopsies to two categories (from the left and right ovary), including normal-high risk and cancer or normal-high risk and endometriosis.
One limiting factor of this study is that the age distribution of the normal-low risk group is larger than in the other groups. Figure 2a illustrates the average fluorescence emission of the normal ovary. Figure 2b illustrates the emission spectra of the normal ovaries, benign neoplasms, and cancers. The most statistically significant differences were observed at UV excitation wavelengths, in particular at 270 and 340nm excitation. At 270 nm excitation wavelength (Figure 2b ), emission intensity of the average cancer sample is the highest while emission intensity of the benign neoplasm is the lowest. Mean emission spectra are separated by approximately one standard deviation. The emission maximum is located at 340 nm which is consistent with tryptophan fluorescence emission.
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Areas of necrotic tumor
Figure 3f: A region of necrotic, cancerous tissue. An example of necrotic cancerous tissue shows the irregular hypointense regions (arrows). In this sample, the OCT images were very similar from location to location.
There were non-significant differences in intensity between the high risk and the low risk group but there was a trend of a difference between these 2 groups. At 340nm excitation wavelength (Figure 2c ), emission intensity of the cancer group is lowest while the benign group has the highest intensity. The emission spectra consist of a main peak at 380 nm and a shoulder at 450 nm emission. The 380 nm peak is consistent with the signal of hydroxypyridinium, a major collagen cross linking residue (14) and the shoulder at 450 nm emission may be due to NAD(P)H remission or re-absorption of fluorescence due to hemoglobin at 420 nm (15, 16) or both.
The intensity differences between the high risk and the low risk group are small and can only be observed between 420 and 500 nm where the average emission of the high risk group is reduced (p<0.05). The inverse intensity relationship between the cancer and benign neoplasm group is further illustrated in Figure 2d with an excitation spectrum at 390 nm emission. The spectrum consists of maximal emission intensities at 270 or 340 nm which is consistent with the influence of tryptophan and hydroxypyridinium. Differ-ences between the cancer group, the normal group and the benign neoplasm group are statistically significant at those two wavelengths (cancer-normal p<0.05, cancer-benign p<0.05). Differences at these wavelengths suggest alterations of the extracellular matrix resulting in a decrease at 340 nm and an increase of protein production, resulting in an increase at 270 nm in the cancer group. In the cancer group, it could be hypothesized that a decrease at 340 nm is due to a breakdown of the extracellular matrix and an increase at 270 nm is due to increased tryptophane which corresponds to an increase in protein synthesis.
Optical Coherence Tomography (OCT)
Twenty one (21) ovaries from 13 patients were imaged with OCT and compared to histology. Samples were divided into four categories: normal, high risk, endometriosis, and neoplasms (including benign and malignant types). The OCT and histological appearance of the tissue varied within each type. Example OCT images and corresponding histology are shown in Figure 3 . The OCT images are 6 mm wide by 1.4 mm deep, the histology images are 2 mm wide by 1.5 mm deep.
The normal ovary (Figure 3a and b) shows some very small cysts (one marked with a black arrow), which do not shadow the underlying tissue. A very small blood vessel casts a distinct shadow (thin arrow). The epithelium is fairly distinct across the whole ovarian surface. Figure 3b was imaged from the ovary of a woman at high risk of ovarian cancer and displays the interesting wavy pattern in the subepithelial area (white arrows). This pattern has been seen in all four categories of ovaries so it may not be diagnostic, although it may be associated with a particular blend of collagen and cellular material which may be of interest. The next high risk ovary
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Technology displays a normal large follicular cyst (Figure 3c ). These cysts were seen in many ovaries and varied greatly in size (probably due both to the inherent size of the cyst and also where in the cyst the cross-sectional OCT image was taken). Endometriosis ( Figure 3d ) was easily identified and consisted of loose tissue on top of the ovary which is characteristic of endometriosis. In these cases, the ovarian surface was irregular. In many of the images taken thus far, there were hypointense, non-shadowing bands about 1 mm deep. Histologically, these appear as bands of connective tissue or actual separations in the tissue. Further imaging is necessary to determine if this is characteristic of endometriosis or simply another feature in these particular ovaries.
Cancer was distinguishable in two ways. First, superficial tissue masses on the surface of the ovary were readily seen. Second, necrotic tissue had very characteristic, irregular hypointense regions. The first cancer is shown in Figure 3e . Also seen in this image is a strong birefringence band. This "artifact" is caused by high concentrations of regular collagen material. Since collagen is birefringent, it rotates the polarization state of light. When the light reflected from the ovary tissue has rotated to a polarization state orthogonal to the light returning from the reference arm, no interference can occur. This is manifested as a dark band in the image. While these bands can be confounding to the untrained eye, their appearance is consistent from tissue to tissue and a trained observer can recognize their presence as indicative of high collagen concentration. The second cancer, seen in Figure 3f , shows 'holes' in the OCT image which histologically looks like areas of necrotic tumor. Loss of the cellular detail is seen more convincingly with OCT than with the histology.
OCT can readily provide information on normal and pathological anatomy: large blood vessels appear as distinct vertical bands due to their shadowing effect, which are common in cancers as they invade tissue. Inclusion cysts appear as well-defined, roughly circular hypointense regions that do not shadow underlying tissue so are distinguishable from stroma. These may be the areas where some cancers arise and judging from the appearance of the cancers with the areas of necrosis, the two look very different. Regions of dense collagen display characteristic birefringence banding artifacts and regions of moderately high collagen content mixed with cells display a distinct "wavy" appearance. Superficial loose or connective tissue can be distinguished from underlying ovarian tissue and malignant, partially necrotic areas appear as hypointense, irregular regions. It appears that the epithelium can be distinguished on the surface of the OCT images.
Confocal Microscopy
Tissue from 20 patients and 28 ovaries was imaged with the confocal micro-endoscope. Samples were divided into four categories: normal, high risk, endometriosis, and cancer (including benign and malignant types). The confocal images revealed interesting micro-structural features of tissue as well as the distribution of cell nuclei on the surface. Two patterns were observed in normal tissue, one associated with intact epithelium and the other with the underlying stroma, which is occasionally exposed by tissue handling. Figure 4a shows images of normal ovary. The surface epithelium is observed as a regular closely-packed uniformly-sized layer of cells, which are easily identifiable. Normal underlying stroma has less densely packed cells with elongated nuclei. These findings agree well with what is seen in histology, although the en face view of the confocal micro-endoscope is clearly different than the cross-sectional view of histology. Nevertheless, the size and distribution of cells can be compared and correlated.
Some of the high risk ovaries show areas of proliferation on the surface that have not been seen on normal ovaries. This appears different than the areas of endometriosis (not shown) which show an increase in the cells on the surface but with a less regular pattern than is seen with the high risk ovary. Figure 4b illustrates the area of surface epithelial proliferation that still retains the regular pattern of surface epithelium but is obviously more than one cell layer thick. There were no other obvious differences observed between low and high risk normal tissue samples, although subtle differences may be identifiable by careful quantitative image analysis, which we are currently investigating. With only two cases of endometriosis, there is as yet insufficient data to identify a characteristic pattern for this condition.
Malignant ovarian tissue typically has a distinctly different appearance on confocal micro-endoscope images. The tissue is generally more heterogeneous and there are often large variations in signal intensity due to the convoluted surface topography. Figure 4c shows a confocal image with dark linear structures corresponding to large blood vessels that are just below the surface which are associated with cancer. Although the tumor is not visible in this portion of the picture, the large vessels are quite obvious in the confocal images, suggesting an ability to image small vessels at this level. Figure 4d shows a confocal image and photomicrograph of a tumor on the ovary. The area on the far right of the H&E photograph shows a small area of tumor (arrow) which corresponds to the area on the confocal image (arrow). This last confocal image portrays the variability in nuclear size and the increase in diameter of the nuclei which are features suggestive of malignancy. Cancer cells look much different from normal cells because the nuclei are irregular and vary in size when compared to the geometric appearance of the surface epithelium from normal ovaries.
Confocal images are currently being analyzed for diagnostic accuracy, but it is clear that this optical technology has sig-nificant potential for scanning the surface and subsurface of the ovary and diagnosing abnormalities on the surface and subsurface that is not visually detectable.
Discussion
Optical technologies have traditionally been used alone to interrogate tissue. However, combinations of technologies may allow improved diagnostic accuracy. Current problems in early detection in ovarian cancer include women with small cancers that are not visible and women who are destined to develop ovarian cancer and have changes on the surface or subsurface that we currently cannot recognize. Improving both of these areas of diagnostic ability could significantly reduce the incidence of ovarian cancer. In addition, women designated at risk, based on their family history, could be reassured that their ovaries were normal and be given an alternative to surgical removal. Combining technologies to improve accuracy in differentiating these women could greatly enhance our clinical recommendations and is the goal of our current research.
Fluorescence spectroscopy has been used to non-invasively measure precancers and cancers in tissue and has gained increasing use in the last decade in cervix, head and neck, Barrett's esophagus, ovary, and lung (8, 9, [15] [16] [17] [18] [19] [20] [21] [22] [23] . Fluorescence spectroscopy measures endogenous signals which are modulated by the presence of four major groups of molecules: structural proteins (collagen and elastin), mitochondrial electron transport molecules (FAD and NAD(P)H), amino acids (tryptophan, tyrosine and phenylalanice), and chromophores in blood (oxy and deoxy hemoglobin which reduce the reemitted signal). The areas that offered the most promising distinctions between groups using fluorescence spectroscopy were located in the UV excitation range at 270 and 340 nm. Tryptophan and structural proteins, particularly collagen and elastin, provide a strong auto-fluorescence signal in this range. Data from invivo measurements in humans at 270 nm excitation are limited due to concerns of mutagenicity which may occur in the UV range, although there is work by Kollias (24) and Yang (25) suggesting this wavelength may have diagnostic potential. This preliminary analysis supports the need for further studies at the UV-B excitation wavelengths, which will be possible with an experimental design limiting tissue exposure. Fairly large variations were observed in the normal (low risk) population, which may be attributed to the wide age distribution of this group, ranging from 18 to 77 years old.
Larger studies are needed to analyze tissue by menopausal status, in addition to diagnostic category.
In the current work, fluorescence spectra were measured from a small volume with a point probe in order to look at a broad range of excitation and emission characteristics. This approach is useful for evaluating whether there are specific spectral regions appropriate for identifying pathology. Once a specific excitation/emission wavelength range is determined, a fluorescence imaging system can be developed as a dedicated clinical tool for this application.
Optical coherence tomography (OCT) is a minimally invasive imaging modality that uses near-infrared light backscattered from index of refraction mismatches to create cross-sectional images (26). OCT typically obtains a resolution of 5-20 µm and a depth of penetration of 1-2 mm and has been used to image tissues in the body that can be accessed either directly or via endoscope or catheter, including the GI tract (27), eye (28), cutaneous blood vessels (29), and coronary blood vessels (30). OCT has been used to study the structure of gynecological tissues. Example images have illustrated the structure of ovary (31, 32), endometrium (32-34) and uterine cervix (33, 35, 36) . From these images, it has been suggested that OCT can differentiate normal structure from cancer or pre-cancer.
We have carefully compared registered OCT images and histology of fresh surgical specimens of normal and diseased ovary to determine what features OCT is capable of resolving, and to which tissue characteristics OCT is sensitive. Changes in collagen are suggested with several of the images that correlate with changes in collagen seen in malignancy. We were also able to see areas of necrosis and blood vessels using OCT, which were indicative of an underlying abnormality in the tissue not detected visually by the surgeon (MB). OCT is capable of providing information on tissuelevel changes, but it is unlikely that OCT will be able to distinguish normal from high-risk ovaries since there are no large-scale tissue changes. However, better enhancement at the molecular level may improve this discrimination. It is unlikely that cancer involving only cellular-level changes can be identified by simply looking at OCT images. However, using texture analysis techniques developed in our lab, it may be possible to differentiate sub-resolution but widespread changes in these ovary (36).
Confocal microscopy has been applied in a number of in vivo imaging applications including skin, eye, teeth, and cervix by several groups (37-52). One area of investigation has been in the diagnosis of skin cancer (38-41, 53). The depth sectioning property of confocal systems allows for high resolution imaging of surface and subsurface structures of thick biological tissues. Catheter-based confocal microscopes have been developed to image tissues deep inside the body. Systems based on both reflectance and fluorescence imaging have been developed. Fluorescence confocal imaging can be done with native auto-fluorescence (typically a weak signal), but is more often performed using exogenous fluorescent dyes. In this study, acridine orange was used because it produces excellent images of cell nuclei and is relatively inexpensive. However, acridine orange is cytotoxic and potentially mutagenic because it intercalates with DNA, and thus may not be appropriate for clinical use. Safer alternative dyes are being sought to make this technique more appropriate for clinical use.
To the best of our knowledge, this is the first study to investigate imaging of the ovary with the fluorescence confocal micro-endoscope. The preliminary results suggest that normal epithelium can be differentiated from benign and malignant lesions of the ovary. However, more work needs to be done with excised tissue samples to identify the patterns of change at early carcinogenesis, as well as to validate the efficacy of this imaging technology in the context of identifying in situ ovarian cancer.
Each imaging modality has strengths and weaknesses. Endogenous fluorescence emission is altered by many variables such as blood on the surface of the tissue or additional blood vessels within tissue. Density of blood vessels might be correlated with amount of hemoglobin reabsorption in fluorescence spectra; combining FS with OCT can document the presence of blood on the surface due to surgery which is differentiated from abnormal vessels suggestive of cancer. Confocal imaging gives excellent cellular detail but lacks the ability to image deep enough into the tissue to find areas of neoplasia that might arise more than 100-200 microns below the surface; depth of penetration could be enhanced with the use of OCT. The combination of the three modalities may well compensate for the limitations of any one technique. In addition, fluorescent dyes can be used as probes of polarity, membrane potential, ion concentration (e.g., Ca++, pH), and various metabolic processes. Fluorescence spectra (emission and/or excitation) of such probes are affected by the local environment, and via spectroscopic measurements, properties of this environment can be determined.
Normal epithelial cells from ovaries containing a malignant lesion and from ovaries from women with an increased risk for ovarian cancer exhibit statistically significant differences in the values of features characterizing the nuclear chromatin pattern (54). Denser granules of chromatin aggregate, which is typical for chromatin in premalignant and malignant cells, suggest that in histologically normal ovarian epithelium, a field effect of "malignancy associated changes" exists. This field effect has important implications for our imaging technology. Changes suggestive of a preneoplastic or an early invasive state may be detectable throughout the ovarian surface and subsurface with imaging technology and may not limited to one part of the ovary. Thus, lesions that are below the limits of visual resolution should be detectable. Earlier detection has the capability to improve survival from this cancer that carries such a high mortality.
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